$30.34
3.84%
Nasdaq, Jul 11, 10:00 pm CET
ISIN
US74838J1016
Symbol
QDEL

Quidel Corporation Stock price

$30.34
-0.63 2.03% 1M
-14.27 31.99% 6M
-14.21 31.90% YTD
-1.14 3.62% 1Y
-73.74 70.85% 3Y
-204.17 87.06% 5Y
+6.74 28.56% 10Y
+24.08 384.66% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
-1.21 3.84%
ISIN
US74838J1016
Symbol
QDEL
Sector

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$4.4b
Net debt
$2.4b
Cash
$127.1m
Shares outstanding
67.5m
Valuation (TTM | estimate)
P/E
negative | 12.4
P/S
0.7 | 0.7
EV/Sales
1.6 | 1.6
EV/FCF
negative
P/B
0.7
Financial Health
Equity Ratio
46.5%
Return on Equity
-68.8%
ROCE
1.6%
ROIC
1.5%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$2.8b | $2.8b
EBITDA
$285.7m | $603.0m
EBIT
$86.0m | $384.3m
Net Income
$-358.7m | $165.6m
Free Cash Flow
$-35.9m
Growth (TTM | estimate)
Revenue
-3.4% | -0.5%
EBITDA
-15.3% | 142.0%
EBIT
-34.7% | 739.1%
Net Income
79.7% | 108.1%
Free Cash Flow
69.8%
Margin (TTM | estimate)
Gross
46.9%
EBITDA
10.3% | 21.8%
EBIT
3.1%
Net
-13.0% | 6.0%
Free Cash Flow
-1.3%
More
EPS
$-5.3
FCF per Share
$-0.5
Short interest
10.0%
Employees
7k
Rev per Employee
$420.0k
Show more

Is Quidel Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Quidel Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Quidel Corporation forecast:

11x Buy
73%
3x Hold
20%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Quidel Corporation forecast:

Buy
73%
Hold
20%
Sell
7%

Financial data from Quidel Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,765 2,765
3% 3%
100%
- Direct Costs 1,467 1,467
1% 1%
53%
1,298 1,298
6% 6%
47%
- Selling and Administrative Expenses 749 749
2% 2%
27%
- Research and Development Expense 213 213
13% 13%
8%
286 286
15% 15%
10%
- Depreciation and Amortization 200 200
3% 3%
7%
EBIT (Operating Income) EBIT 86 86
35% 35%
3%
Net Profit -359 -359
80% 80%
-13%

In millions USD.

Don't miss a Thing! We will send you all news about Quidel Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quidel Corporation Stock News

Neutral
PRNewsWire
7 days ago
New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO , July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has appointed two industry-leading ...
Neutral
PRNewsWire
about one month ago
―Company Intends to Acquire LEX Diagnostics Upon U.S. FDA Clearance― ―Company Plans to Discontinue Savanna® Platform Development― ―Company Reaffirms Full Year 2025 Financial Guidance ― ―Company to Host Conference Call Today at 5:00 p.m. ET― SAN DIEGO, June 3, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro di...
Neutral
Business Wire
about 2 months ago
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will participate in two upcoming investor conferences: William Blair 45th Annual Growth Stock Conference, Wednesday, Ju...
More Quidel Corporation News

Company Profile

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Head office United States
CEO Brian Blaser
Employees 6,600
Founded 2022
Website www.quidelortho.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today